Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00202449 · ClinicalTrials.gov registry record · NA
Prazosin vs Paroxetine in Combat Stress-Related Post-Traumatic Stress Disorder (PTSD) Nightmares & Sleep Disturbance
A NA study, sponsored by Seattle Institute for Biomedical and Clinical Research.
- Terminated
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT00202449 is a NA study that was terminated before completion, run by Seattle Institute for Biomedical and Clinical Research. The registered enrollment target is 59 participants.
The verdict
NCT00202449, a NA study, was terminated before completion, sponsored by Seattle Institute for Biomedical and Clinical Research.
- TERMINATED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
The purposes of this study are: * to evaluate the efficacy and tolerability of the drug prazosin compared to placebo for combat stress-related nightmares, sleep disturbance and overall function in recently combat-exposed returnees from Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF). * to evaluate the effects of the selective serotonin reuptake inhibitor (SSRI) paroxetine on behavioral symptoms and overall function in this population.
Interventions
- DRUG Placebo
- DRUG paroxetine
- DRUG prazosin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2004-07 |
| Est. Completion | 2008-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00202449
The ClinicalTrials.gov registry entry for NCT00202449 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Institute for Biomedical and Clinical Research, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00202449 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00202449 about?
NCT00202449 is a clinical study titled "Prazosin vs Paroxetine in Combat Stress-Related Post-Traumatic Stress Disorder (PTSD) Nightmares & Sleep Disturbance". The purposes of this study are: * to evaluate the efficacy and tolerability of the drug prazosin compared to placebo for combat stress-related nightmares, sleep disturbance and overall function in recently combat-exposed returnees from Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (O...
What is the current status of trial NCT00202449?
This trial is currently terminated. It is a NA study. The enrollment target is 59 participants. The study started on 2004-07. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00202449?
The interventions under investigation include: Placebo (DRUG), paroxetine (DRUG), prazosin (DRUG).
Who is sponsoring clinical trial NCT00202449?
This trial is sponsored by Seattle Institute for Biomedical and Clinical Research, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.